NASDAQ · Biotechnology

VIR (VIR) Stock

$8.85 +0.57% NASDAQ: VIR Healthcare

Valuation

MetricValue
Price$8.85
Market Cap$1.49B
P/E Ratio-3.71
P/B Ratio1.57
P/S Ratio22.19
EPS (TTM)$-2.33
52-Week High$11.66
52-Week Low$4.16
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-47.69%
ROA-24.79%
ROCE-61.18%
Gross Margin2.75%
Operating Margin-7.05%
Net Margin-6.76%
Debt/Equity0.11
Current Ratio5.53

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.1B$1.6B$86.0M$74.0M$69.0M
Operating Profit$421.0M$833.0M$-684.0M$-587.0M$-468.0M
Net Profit$529.0M$516.0M$-615.0M$-522.0M$-438.0M
EPS$3.96$3.83$-4.59$-3.83$-3.16
Op Margin38.4%51.6%-794.0%-791.3%-682.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.0B$2.8B$1.9B$1.4B$1.0B
Total Liabilities$522.0M$724.0M$329.0M$248.0M$238.0M
Cash$348.0M$849.0M$242.0M$223.0M$234.0M
Borrowings$137.0M$128.0M$125.0M$98.0M$187.0M

Latest News

Vir Biotechnology to Host Conference Call for Second Quarter 2026 Financial Results Business Wire · Jul 22, 2026 VIR: Lowering target price to $8.00 Argus Research · Jul 22, 2026 Brii Bio Announces Topline End-of-Treatment Data from Phase 2b ENRICH and ENHANCE Studies for the Treatment of Chronic Hepatitis B PR Newswire · Jul 3, 2026 Jade Biosciences Announces Appointment of Mark Eisner, M.D., M.P.H., to Board of Directors GlobeNewswire · Jun 26, 2026 Vir Biotechnology Announces Appointment of Timothy Coughlin to its Board of Directors Business Wire · Jun 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-48.0M$1.7B$-779.0M$-446.0M$-392.0M
Investing Cash Flow$-163.0M$-1.3B$143.0M$492.0M$306.0M
Financing Cash Flow$15.0M$7.0M$0$0$0
Net Cash Flow$-88.0M$505.0M$-606.0M$57.0M$-78.0M
Free Cash Flow$-69.0M$1.6B$-800.0M$-454.0M$-397.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-23.06
EV / EBITDA-2.37
FCF Yield-30.60%
Quick Ratio7.11
Interest Coverage—
Return 1Y59.83%
Return 3Y-33.36%
Return 5Y-74.65%

Ownership

Insiders Held6.59%
Institutions Held80.49%
Institutions Float Held86.17%
Institutional HolderSharesReport Date
Blackrock Inc.17,998,3292026-03-31
Arch Venture Management, Llc12,916,6632026-03-31
SB Investment Advisers (UK) LTD10,948,0932026-03-31
Vanguard Portfolio Management LLC9,215,5772026-03-31
GSK plc8,550,9542026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About VIR

VIR is led by CEO Marianne De Backer, employs 408 people, headquartered in US, publicly traded since 2019.

VIR stock trades at $8.85 with a market capitalization of $1.49B. The stock is valued at a price-to-earnings (P/E) ratio of -3.71, price-to-book of 1.57, price-to-sales of 22.19. Over the past 52 weeks the stock has ranged between $4.16 and $11.66, and currently trades 24.1% below its 52-week high.

On profitability, VIR generates a return on equity (ROE) of -47.69%, return on capital employed of -61.18%, an operating margin of -7.05%, a net profit margin of -6.76%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides